QuikClot® hemostatic devices help patients survive traumatic blood loss 

The unpredictable nature of patient care requires a reliable way to achieve hemostasis. QuikClot® hemostatic devices are as safe and easy to use as standard gauze, but stop bleeding significantly faster when applied with pressure.1,2 They help reduce the need for more expensive treatments and establish stability to get patients to the next level of care.4

Learn more about QUIKCLOT®


Unlike other hemostatic agents, QuikClot® devices use proprietary kaolin technology

QuikClot® devices are impregnated with kaolin, an inorganic mineral that has been clinically shown to accelerate the body’s natural coagulation cascade.1,4 Kaolin is not known to cause allergic responses1,4 or exothermic reactions. It contains no shellfish.

Learn more about kaolin


QuikClot® devices can be used throughout your hospital

QuikClot® devices are kaolin-impregnated, nonwoven gauzes that provide efficient hemostasis solutions for external bleeding in the trauma center, as well as other hospital and healthcare settings. They come in familiar formats and various sizes, with or without X-ray detectable strips, and are adaptable to most departments, such as:

  • Trauma centers
  • Emergency medicine
  • Interventional radiology
  • Cardiology
  • Critical care
  • Dermatology
  • OB/GYN 

Request an inservice from a local Z-Medica Sales Rep


QuikClot® devices stop local and severe bleeding

Indications for QuikClot® hospital products include:
 

  • A topical dressing for the local management of bleeding wounds such as cuts, lacerations, and abrasions. It may also be used for temporary treatment of severely bleeding wounds such as surgical wounds (operative, postoperative, dermatological, etc.) and traumatic injuries.
  • Local management and control of surface bleeding from vascular access sites, percutaneous catheters, or tubes utilizing introducer sheaths up to 12 Fr.
  • Local management and control of surface bleeding from vascular access sites, percutaneous catheters, or tubes utilizing introducer sheaths up to 7 Fr. in patients on drug-induced anticoagulation treatment. 

 Use QuikClot® devices for:

  • Cuts
  • Lacerations
  • Abrasions
  • Surgical wounds (operative, postoperative, dermatological, etc.)
  • Traumatic injuries
  • Vascular access sites
  • Percutaneous catheters
  • Tubes utilizing introducer sheaths

Learn more about indications for use


How can we serve you better? 

Let us help assess the bleeding control needs of your team, department, or entire facility. We can recommend the QuikClot® devices that are right for the situations you may encounter. 

Contact us


References: 1. Trabattoni D, Montorsi P, Fabbiocchi F, Lualdi A, Gatto P, Bartorelli A. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21:1687-1691. 2. Politi L, Aprile A, Paganelli C, et al. Randomized clinical trial on short-time compression with kaolin-filled pad: a new strategy to avoid early bleeding and subacute radial artery occlusion after percutaneous coronary intervention. J Interven Cardiol. 2011;24:65-72. 3. Trabattoni D, Gatto P, Bartorelli A. A new kaolin-based hemostatic bandage use after coronary diagnostic and interventional procedures. Int J Cardiol. 2012;156(1):53-54. 4. Lamb KM, Pitcher HT, Cavarocchi NC, Hirose H. Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy. Open Cardiovasc Thorac Surg J. 2012;5:8-10. 5. Pahari M, Moliver R, Lo D, Pinkerton D, Basadonna G. QuikClot® Interventional™ Hemostatic Bandage (QCI): a novel hemostatic agent for vascular access. Cath Lab Digest. 2010;18(1):28-30. http://www.cathlabdigest.com/articles/QuikClot®-Interventional™-Hemostatic-Bandage-QCI-A-Novel-Hemostatic-Agent-Vascular-Access. Accessed on August 10, 2014. 6. Tactical Combat Casualty Care Guidelines 2 June 2014. http://www.usaisr.amedd.army.mil/pdfs/TCCC_Guidelines_140602.pdf. Accessed March 25, 2015. 7. Margolis J. Initiation of blood coagulation by glass and related surfaces. Journal Physiol 1957;137:95-109. 8. Data on file. 9. Curry N, Hopewell S, Doree C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92. 10. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safetry evaluation of new hemostatic agents, smectite granules, and kaolin covered gauze in vascular injury wound model in swine. J Trauma. 2010;68:269-278. 11. Kheirabadi BS, Scherer MR, Estep JS, Dubick MA, Holcomb JB. Determination of efficacy of new hemostatic dressing in a model of extremity arterial hemorrhage in swine. J Trauma. 2009;67:450-460. 12. Kheirabadi BS. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J. 2011;25-37. 13. Dee KC, Puleo DA, Bizios R. Tissue-Biomaterial Interactions. Hoboken: Wiley & Sons, 2002. 14. Stop the Bleeding Coalition website http://www.stopthebleedingcoalition.com/get-the-facts.html. Updated: 18 July 2014. Accessed 24 February 2016. 15. Blair, J. Pete, and Schweit, Katherine W. (2014). A Study of Active Shooter Incidents, 2000 - 2013. Texas State University and Federal Bureau of Investigation, US Department of Justice, Washington D.C. 2014. 16. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006; 60:S3-S11.

Show ReferencesHide References


 

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Continue